Advertisement
Screener

BioXcel Therapeutics, Inc. (BTAI) Deferred Tax Assets, Valuation Allowance

2.8 / 5 stars · 68/120 Roast Me

BioXcel Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance

BioXcel Therapeutics, Inc. (BTAI) had Deferred Tax Assets, Valuation Allowance of $213.93 million as of 2025-12-31, per its 10-K filed 2026-03-27.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-27

  • 2025-12-31: Deferred Tax Assets, Valuation Allowance $213.93M.
  • 2024-12-31: Deferred Tax Assets, Valuation Allowance $192.15M.
  • 2023-12-31: Deferred Tax Assets, Valuation Allowance $173.68M.
  • 2022-12-31: Deferred Tax Assets, Valuation Allowance $118.37M.
Period endDeferred Tax Assets, Valuation AllowanceDeferred Tax Assets, Valuation Allowance as first filed
2025-12-31$213.93M
10-K · filed 2026-03-27
2024-12-31$192.15M
10-K · filed 2026-03-27
2023-12-31$173.68M
10-K · filed 2025-03-28
2022-12-31$118.37M
10-K · filed 2024-03-22
2021-12-31$71.90M
10-K · filed 2023-03-16
2020-12-31$41.72M
10-K · filed 2022-03-11
2019-12-31$15.25M
10-K · filed 2021-03-12
$15.25M
10-K · filed 2020-03-09
2018-12-31$6.26M
10-K · filed 2020-03-09
2017-12-31$1.16M
10-K · filed 2019-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
ORAGENICS INC (OGEN)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02